SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001493152-19-016286
Filing Date
2019-10-31
Accepted
2019-10-31 16:57:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 formprer14a.htm PRER14A 811853
2 proxy_001.jpg GRAPHIC 139384
3 proxy_002.jpg GRAPHIC 111335
4 proxy_003.jpg GRAPHIC 142029
5 proxy_004.jpg GRAPHIC 111524
  Complete submission text file 0001493152-19-016286.txt   1507864
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-13789 | Film No.: 191184335
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences